Sepsivac Injection 0.6 ml

Sepsivac 0.6Ml Inj belongs to the group of medicines called immunotherapeutic agents used to treat leprosy. It is used to treat advanced non-small-cell lung cancer in combination with other medicines and as adjuvant therapy in sepsis. Leprosy is an infection caused by slow-growing bacteria called Mycobacterium leprae.

Sepsivac 0.6Ml Inj contains Mycobacterium W and Sodium chloride. Sepsivac 0.6Ml Inj works by altering the biological response or modifying the actions of the immune system of individuals to various pathological conditions.

Sepsivac 0.6Ml Inj should be administered by a healthcare professional. Do not self-administer. In some cases, you may experience some common side effects like injection site erythema (redness) and ulceration, nausea, vomiting, diarrhoea, pain, weakness and loss of appetite. Most of these side effects of Sepsivac 0.6Ml Inj do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, reach out to your doctor.

Consult your doctor if you are pregnant or breastfeeding. It is not known whether Sepsivac 0.6Ml Inj alters the ability to drive; do not drive or operate machinery if you experience any symptoms that affect your ability to concentrate and react. It is not known whether it is safe to consume alcohol with Sepsivac 0.6Ml Inj. However, as a precautionary measure, it is advisable not to take or limit alcohol.

Sepsivac 0.6Ml Inj belongs to the group of medicines called immunotherapeutic agents. It contains heat-killed strains of bacteria named 'Mycobacterium w' which is a non-pathogenic mycobacterium and has immunomodulatory properties. It is used as immunotherapy in leprosy, sepsis and in advanced non-small cell lung cancer along with other anti-cancer medicines. It works by altering the biological response of an individual to various pathological conditions.

• Injection site erythema (redness) and ulceration
• Nausea
• Vomiting
• Diarrhoea
• Pain
• Weakness
• Constipation
• Loss of appetite

Inform your doctor if you are allergic to any of the contents of Sepsivac 0.6Ml Inj, if you have a fever, generalised septic skin conditions, chronic debilitating conditions or any other health conditions. Consult your doctor if you are pregnant, planning for pregnancy or if you are breastfeeding. Keep your doctor informed about your health condition and all the medicines you take before taking Sepsivac 0.6Ml Inj to rule out any side effects.

Drug-Drug Interactions: Sepsivac 0.6Ml Inj may have interaction with medications that are cytotoxic (methotrexate, cyclophosphamide), and anti-leprosy drugs (rifampicin, clofazimine).

Drug-Food Interactions: No interactions were found/established

Drug-Disease Interactions: Sepsivac 0.6Ml Inj may have interactions with allergic reactions, septic skin condition or existing eczema.

• METHOTREXATE
• CYCLOPHOSPHAMIDE
• RIFAMPICIN
• CLOFAZIMINE

• Eat a healthy diet and exercise regularly to maintain proper weight.
• De-stress yourself by meditating, reading books, taking a warm bubble bath or listening to soothing music.
• Performing yoga may also help in improving both physical and mental health.
• Maintain a healthy weight by performing regular low-strain exercises and eating healthy food.
• Include leafy vegetables, citrus fruits, fatty fish, berries, yoghurt, apples, peaches, cauliflower, cabbage, broccoli, beans, and herbs in your diet.
• Get optimal sleep; rest well.
• Avoid fast food, fried food, processed meats, refined carbs and added sugars.
• Avoid smoking and alcohol consumption.

Leprosy: Hansen's disease, also known as leprosy is an infection caused by Mycobacterium leprae, a slow-growing bacteria. The disease primarily affects the skin, peripheral nerves, upper respiratory tract mucosal surfaces, and the eyes.

Sepsis: Sepsis is a potentially fatal immune response to infection. It happens when your immune system overreacts to an infection and starts causing damage to your own tissues and organs.

Non-small cell lung cancer: Non-small cell lung cancer is a disease in which malignant (cancer) cells develop in lung tissues. The most important risk factor for non-small cell lung cancer is smoking.